Search
Prestige Consumer Healthcare Inc
PBHAdd to Watchlist
46.060USD
+0.600+1.32%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
2.18BMarket Cap
11.73P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.32%
5 Days
-3.03%
1 Month
-4.04%
6 Months
-26.08%
Year to Date
-25.34%
1 Year
-45.42%
Key Figures
45.550Open
46.390High
724.38KVolume
11.73P/E TTM
10.15P/E Dynamic
--Dividend TTM
1.53%Turnover Ratio
45.460Prev. Close
45.225Low
20.32MTurnover
10.16P/E Static
1.15P/B
0.00%Div Yield TTM
5.52%ROA
87.12052wk High
0.79Volume Ratio
214.60MNet Profit
47.32MShares
3.9273EPS TTM
0.37Beta
10.22%ROE
42.62052wk Low
2.56%Amplitude
50.02%Gross Margin
2.18BMarket Cap
-3.25Reward/Risk
1.63%Risk Rate
TradingKey Stock Score of Prestige Consumer Healthcare Inc
Currency: USD Updated: 2026-06-23Key Insights
Prestige Consumer Healthcare Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 66.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Prestige Consumer Healthcare Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Prestige Consumer Healthcare Inc Highlights
StrengthsRisks
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Undervalued
The company’s latest PE is 11.73, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 57.56M shares, increasing 6.12% quarter-over-quarter.
Held by John Rogers
Star Investor John Rogers holds 5.25M shares of this stock.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
66.000
Target Price
+45.18%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Prestige Consumer Healthcare Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Prestige Consumer Healthcare Inc Info
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Ticker SymbolPBH
CompanyPrestige Consumer Healthcare Inc
CEOLombardi (Ronald M)
Websitehttps://www.prestigebrands.com/
Related Instruments
+0.54%
+3.37%
+2.07%
+2.98%
+3.54%
+2.60%
+0.66%
+3.33%
+0.14%
-1.44%
+0.32%
+1.53%
+2.59%
-0.36%
+2.58%
0.00%
+0.90%
-5.50%
+2.77%
+2.33%Popular Instruments
71.369
-1.576 (-2.16%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4045.250
-65.500 (-1.59%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62370.620
-70.080 (-0.11%)
381.610
-23.440 (-5.79%)
FAQs
What is the current price of Prestige Consumer Healthcare Inc (PBH)?
The current price of Prestige Consumer Healthcare Inc (PBH) is 46.06.
What is the symbol of Prestige Consumer Healthcare Inc?
The ticker symbol of Prestige Consumer Healthcare Inc is PBH.
What is the 52-week high of Prestige Consumer Healthcare Inc?
The 52-week high of Prestige Consumer Healthcare Inc is 87.12.
What is the 52-week low of Prestige Consumer Healthcare Inc?
The 52-week low of Prestige Consumer Healthcare Inc is 42.62.
What is the market capitalization of Prestige Consumer Healthcare Inc?
The market capitalization of Prestige Consumer Healthcare Inc is 2.18B.
Is Prestige Consumer Healthcare Inc (PBH) currently rated as Buy, Hold, or Sell?
According to analysts, Prestige Consumer Healthcare Inc (PBH) has an overall rating of Buy, with a price target of 66.00.
What is the Earnings Per Share (EPS TTM) of Prestige Consumer Healthcare Inc (PBH)?
The Earnings Per Share (EPS TTM) of Prestige Consumer Healthcare Inc (PBH) is 3.93.
